Dr. Uqba Khan, MD

  • New York, NY
  • Hematologist and oncologist
NPI1780923920PAC ID0648562850
Medicare services, 2024
748
Medicare patients, 2024
155
Part D claims, 2024
313
Publications
44
Clinical trials
1
Practice address
525 East 68th Street, New York, NY 10065
Practice phone
Call (212) 746-5454
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

See all 6 affiliations

Find Dr. Khan's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Uqba Khan is a hematologist and oncologist in New York, New York

Dr. Khan practices at NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital.

Dr. Khan's NPI, 1780923920, was assigned on February 7, 2013. Dr. Khan graduated from Allama Iqbal Medical College in 2008. Dr. Khan's New York license number on file is 293041.

NPI and contact details
Medicare PAC ID
0648562850
NPI enumeration date
February 7, 2013
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(212) 746-5454
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
44
Medical school graduation
2008

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Uqba Khan practices at NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York

Dr. Khan's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center, at 525 East 68th Street, New York, NY 10065 in New York County. The practice phone is (212) 746-5454.

Source: Dmand AI Affiliation Data

Dr. Uqba Khan is affiliated with 4 sites of care and 2 medical groups

Dr. Khan's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital. The medical group on file is NewYork-Presbyterian Medical Group/Westchester. Dmand AI also links Dr. Khan to 2 more clinical labs, 1 group practice or clinic and 1 medical group, each named with a free account.

See all 6 affiliations for Dr. Khan

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Uqba Khan's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Khan practices, 4 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
NewYork-Presbyterian/Weill Cornell Medical CenterAvailable with a free account
+3 more sites and 1 medical groupAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Khan practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across NewYork-Presbyterian Hospital and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Uqba Khan is one of 996 hematologists and oncologists in New York

Hematology and oncology is Dr. Khan's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Khan is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Khan's licenses on file in 2 states: New York and Michigan.

Specialties and state licenses

  • Hematology and oncology, New YorkPrimaryLicense 293041 · 2018 to 2025 · taxonomy 207RH0003X
  • Michigan license2015 to 2018

Clinical focus

Dmand AI lists chronic anemia, chronic leukemia, lung cancer and multiple myeloma among the conditions Dr. Khan treats.

Hematologists and oncologists near Dr. Khan

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Uqba Khan billed Medicare for 748 services in 2024

CMS data shows 748 Medicare services from Dr. Khan across 10 procedure codes in 2024, for 155 Medicare patients. Medicare paid $48,177 for them.

Medicare services, 2024748
Medicare patients155
Paid by Medicare$48,177
Procedure codes10

Dr. Khan's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 5752024: 47817%
Other services
2023: 02024: 257
Surgery
2023: 02024: 13

Where Dr. Khan's Medicare services took place, 2024

  • In an office253%
  • In a facility72397%

Dr. Khan compared with the New York median for hematologists and oncologists, 2024

  • Dr. Khan
  • New York median
Medicare services
748vs 66812% above
Medicare patients
155vs 21026% below
Part D claims
187vs 25828% below

Medians across 940 hematologists and oncologists in New York with Dmand AI profiles that report each measure.

Dr. Khan's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Khan

Need commercial claims for Dr. Khan?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Khan and other hematologists and oncologists in New York.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Uqba Khan treated 155 Medicare patients in 2024, average age 74

CMS counts 155 Medicare patients who saw Dr. Khan in 2024. The largest group is 65 to 74, with 70 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 45% are also on Medicaid. Their average risk score is 2.54, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Khan's median patient age at 71, with 62% women.

Medicare patients, 2024155
Average age74
Average risk score2.54
Also on Medicaid45%

Dr. Khan's Medicare patients by age, 2024

Dr. Khan's Medicare patients by sex, 2024

  • Women9461%
  • Men6139%

Chronic conditions among Dr. Khan's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol75%
  3. Diabetes54%
  4. Arthritis52%
  5. Ischemic heart disease41%
  6. Cancer40%
  7. Chronic kidney disease39%
  8. Heart failure36%

Share of Medicare patients with each condition. A patient can have several.

Dr. Khan's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 71

Patient panel by sex, all payers

  • Women62%
  • Men37%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Uqba Khan wrote 313 Medicare Part D claims in 2024

In 2024, Dr. Khan wrote 313 Medicare Part D claims for 65 patients. 81% of them were for generic drugs. CMS names the drug for 187 of them, across 7 drugs with 11 or more claims each, at $18,475 in total drug cost. In 2023, CMS named 100 claims across 5 drugs.

Part D claims, 2024313
Drugs named by CMS7
Total drug cost$18,475
Part D patients65

Dr. Khan's Part D claims by kind of drug, 2024

  • Generic255 claims81%
  • Brand-name and other58 claims19%

Dr. Khan's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Khan's Part D claims, 2024

  • Opioids9%28 of 313 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 1002024: 18787%

Drugs named by CMS: 7 in 2024, 5 in 2023.

See all prescribing by Dr. Khan

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Uqba Khan scored 94 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Khan for performance year 2024, reported as part of a group. Dr. Khan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Dr. Khan's MIPS scores, performance year 2024

  • 94of 100Final score
  • 84.7of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities
  • 71of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Khan by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Uqba Khan has 44 publications on record

Dmand AI links 44 papers to Dr. Khan, published from 2014 to 2024. 2017 was the busiest year, with 6. The most frequent topics are Carcinoma, Hepatocellular, Liver Neoplasms and Nivolumab. Dr. Khan has published most often in J Immunother Cancer. Dr. Khan's most frequent co-authors are Thomas Urban Marron, MD, PhD, Tomi Jun and Anushi Bulumulle, MD.

Papers44
Years published2014 to 2024

Dr. Khan's papers by year, 2014 to 2024

Topics Dr. Khan writes about most

  • Carcinoma, Hepatocellular
  • Liver Neoplasms
  • Nivolumab
  • Antineoplastic Combined Chemotherapy Protocols
  • Immune Checkpoint Inhibitors
  • Stomach Neoplasms
  • Adenocarcinoma
  • Antineoplastic Agents

Dr. Khan's most frequent co-authors

Recent publications by Dr. Khan

See all 44 publications and co-authors

See who Dr. Khan researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Khan works with, so you can find a warm path to the right hematologists and oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Uqba Khan has worked on 1 clinical trial

Dmand AI links Dr. Khan to 1 clinical trial. 1 is still active or recruiting.

Investigators on the most trials with Dr. Khan

Recent clinical trials with Dr. Khan

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Uqba Khan received $62,532 in industry payments from 2016 to 2025

CMS Open Payments shows 95 general payments to Dr. Khan from 26 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 45% of the total. BeOne Medicines USA, Inc. paid the most, $27,565.

General payments to Dr. Khan by program year, 2016 to 2025

General payments to Dr. Khan by kind, 2016 to 2025

$62.5Kin total
  • Consulting fees$28,40045%
  • Speaker and faculty fees$25,20040%
  • Travel and lodging$6,67711%
  • Food and beverage$2,0843%
  • Education$1710%

Companies that paid Dr. Khan the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Khan

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Uqba Khan has 2 awards and honors on record

Dmand AI lists 2 awards for Dr. Khan, most recently New York Rising Stars 2020 in 2020.

Awards and honors for Dr. Khan

  1. 2020
    • New York Rising Stars 2020
  2. 2018
    • Merit Award

Source: Dmand AI Professional Profile Data

Dr. Uqba Khan graduated from Allama Iqbal Medical College

Dr. Khan graduated from Allama Iqbal Medical College in 2008. Dr. Khan is a member of AACR and ASCO.

  1. Medical schoolAllama Iqbal Medical College
  2. Board certified in hematologyAmerican Board of Internal Medicine
  3. Board certified in internal medicineAmerican Board of Internal Medicine
  4. Board certified in medical oncologyAmerican Board of Internal Medicine

Source: Dmand AI Professional Profile Data

Dr. Uqba Khan accepts plans from 17 insurance carriers

Dr. Khan is in network with 17 carriers, including Elevance, Aetna and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.

  • Elevance
  • Aetna
  • United Healthcare
  • Blue Cross Blue Shield of Michigan
  • HCSC
  • Aspirus Health Plan
  • Blue Cross Blue Shield of Massachusetts
  • Cigna
  • +9 more carriersWith a free account

Plan types Dr. Khan accepts, by number of carriers

  1. PPO11
  2. Medicare9
  3. HMO7
  4. EPO5
  5. POS5
  6. Medicaid3

Source: Dmand AI Insurance Network Data

Sources for Dr. Uqba Khan's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Awards and committee rolesDmand AI Professional Profile Data
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Uqba Khan

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Uqba Khan's NPI number?

Dr. Uqba Khan's NPI number is 1780923920. It was assigned on February 7, 2013, and it is active in the NPI Registry.

What kind of doctor is Dr. Uqba Khan?

Dr. Uqba Khan is a hematologist and oncologist in New York, New York. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. Uqba Khan practice?

Dr. Khan practices at 525 East 68th Street, New York, NY 10065. Dr. Khan's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital. Dmand AI also links Dr. Khan to 2 clinical labs, 1 group practice or clinic and 1 medical group.

What is Dr. Uqba Khan's office phone number?

The practice phone on file for Dr. Khan is (212) 746-5454.

What is Dr. Uqba Khan's medical license number?

Dr. Khan's New York license number on file is 293041, one of the licenses on file in 2 states.

Which states has Dr. Uqba Khan been licensed in?

Dmand AI has state licenses on file for Dr. Khan in New York (2018 to 2025) and Michigan (2015 to 2018).

Which hospitals is Dr. Uqba Khan affiliated with?

Dr. Khan practices at NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York.

What medical group is Dr. Uqba Khan part of?

Dr. Khan is linked to NewYork-Presbyterian Medical Group/Westchester. Dmand AI links Dr. Khan to 1 more medical group.

Does Dr. Uqba Khan accept Medicare?

Yes. CMS data shows Dr. Khan billed Medicare for 748 services in 2024, and Dr. Khan accepts Medicare assignment.

What is Dr. Uqba Khan's MIPS score?

Dr. Khan's MIPS final score for performance year 2024 is 94 out of 100, reported as part of a group.

Show 10 more questionsShow fewer questions

How many Medicare patients does Dr. Uqba Khan see?

CMS counts 155 Medicare patients who saw Dr. Khan in 2024, with an average age of 74.

Is Dr. Uqba Khan board certified?

Yes. Dr. Khan is board certified in hematology by the American Board of Internal Medicine.

What services does Dr. Uqba Khan bill to Medicare?

In 2024, Dr. Khan's most billed Medicare services were medicare service (G2211), office visit, established patient (99213) and office visit, established patient (99214).

Where did Dr. Uqba Khan go to medical school?

Dr. Khan graduated from Allama Iqbal Medical College in 2008.

What drugs does Dr. Uqba Khan prescribe most?

In 2024 Medicare Part D data, Dr. Khan's most prescribed drugs by claims were Ondansetron HCl, Prochlorperazine Maleate and Dexamethasone.

Has Dr. Uqba Khan received payments from drug or device companies?

CMS Open Payments shows $62,532 in general payments to Dr. Khan from 26 companies from 2016 to 2025. The largest total came from BeOne Medicines USA, Inc.

How long has Dr. Uqba Khan been practicing?

Dr. Khan graduated from medical school in 2008, 18 years ago.

Does Dr. Uqba Khan do research?

Dmand AI links 44 publications to Dr. Khan, published from 2014 to 2024. Dr. Khan has worked on 1 clinical trial.

Who does Dr. Uqba Khan publish with?

Dr. Khan's most frequent co-authors are Thomas Urban Marron, MD, PhD (13 shared papers), Tomi Jun (12 shared papers) and Anushi Bulumulle, MD (9 shared papers).

What insurance does Dr. Uqba Khan accept?

Dr. Khan is in network with 17 carriers, including Elevance, Aetna and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.

Selling to hematology and oncology practices?

See hematologists and oncologists in New York by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)